Tagged with Merck

Boehringer Ingelheim, Bayer & Merck KGaA: New Leaders, New Launches, New Pressures
Korea’s Drug Pricing and Incentive Reform: What You Need to Know
Christoph Hamann – General Manager, Merck Healthcare Korea
Can Steady Hand Belén Garijo Pick the Right Path at Sanofi?
Regulatory Independence in Hong Kong: Just Around the Corner?
Hong Kong: A Dynamic Local Market
Germany Pharma News: Boehringer & Merck Acquisitions, Drug Pricing Reforms, Bayer Layoffs
US Pharma Roundup: Lilly Goes All-In on AI; Trump’s Drug Pricing Deals; Organon CEO Resigns
Pipelines, Politics & Pricing: The Challenges Facing Big Pharma’s New CEOs
Denmark: Medical R&D Outlier
The Bet to Double Denmark’s Life Science Power
Tony Cheng – Managing Director & GM Hong Kong & Macau, Merck Healthcare
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here